Categories

Brands

Active Ingredient

Warehouses

Join Jetroids on Telegram

Cabergoline Information

Click here to view all Cabergoline products
2D Structure of Cabergoline
2D Structure
3D Structure of Cabergoline
3D Structure

Cabergoline is a medication that belongs to a class of drugs called dopamine agonists. It is primarily used to treat medical conditions associated with an excess of the hormone prolactin, such as hyperprolactinemia, prolactinomas (benign tumors of the pituitary gland that produce prolactin), and related disorders.

Cabergoline works by stimulating dopamine receptors in the brain. Dopamine is a neurotransmitter that plays a crucial role in regulating various functions in the body, including the secretion of prolactin. By activating dopamine receptors, cabergoline inhibits the release of prolactin from the pituitary gland, thereby reducing its levels in the body.

By normalizing prolactin levels, cabergoline helps alleviate symptoms associated with hyperprolactinemia, such as irregular menstrual periods, infertility, breast milk production in non-pregnant women, and decreased libido. It can also shrink prolactinomas and prevent their growth in some cases.

It is important to note that cabergoline should only be used under the guidance and prescription of a healthcare professional, as it may have potential side effects and interactions with other medications.

Synonyms of Cabergoline

  • cabergoline
  • 81409-90-7
  • Dostinex
  • Cabaser
  • Cabaseril
  • Cabergolinum [Latin]
  • Cabergolina [Spanish]
  • Cabergolinum
  • Cabergolina
  • Galastop
  • FCE-21336
  • FCE 21336
  • Sogilen
  • Velactis
  • Dostinex (TN)
  • Cabaser (TN)
  • Cabergoline [USAN:BAN:INN]
  • C26H37N5O2
  • 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea
  • BRN 6020775
  • UNII-LL60K9J05T
  • CHEBI:3286
  • LL60K9J05T
  • DTXSID6022719
  • Cabergoline [USAN:USP:INN:BAN]
  • CG-101
  • 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
  • 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea
  • (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide
  • 1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate
  • (6aR,9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
  • (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide
  • DTXCID502719
  • (6aR,9R,10aR)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-7-prop-2-enyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
  • (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide
  • (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide
  • 1-[3-(dimethylamino)propyl]-3-ethyl-1-{[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]carbonyl}urea
  • Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-beta)-
  • Ergoline-8beta-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-
  • CAS-81409-90-7
  • SR-05000001493
  • Caberlin
  • 1-[(6-allylergolin-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea
  • NCGC00167821-01
  • MFCD00867887
  • CABERGOLINE [MI]
  • CABERGOLINE [INN]
  • CABERGOLINE [JAN]
  • CABERGOLINE [USAN]
  • D04EGX
  • GTPL37
  • CABERGOLINE [VANDF]
  • CABERGOLINE [MART.]
  • SCHEMBL42292
  • CABERGOLINE [USP-RS]
  • CABERGOLINE [WHO-DD]
  • BIDD:GT0775
  • Cabergoline (JAN/USP/INN)
  • Cabergoline (JAN/USAN/INN)
  • Cabergoline [USAN:INN:BAN]
  • CHEMBL1201087
  • Cabergoline, >=98% (HPLC)
  • CABERGOLINE [ORANGE BOOK]
  • CABERGOLINE [EP MONOGRAPH]
  • HMS2090A09
  • HMS3886H05
  • CABERGOLINE [USP MONOGRAPH]
  • Tox21_112589
  • BDBM50426497
  • s5842
  • 1-Ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'beta-carbonyl)urea
  • AKOS015961587
  • C26-H37-N5-O2
  • Tox21_112589_1
  • DB00248
  • FCE-21336FCE-21336
  • CABERGOLINE [EMA EPAR VETERINARY]
  • NCGC00344544-01
  • AC-26126
  • HY-15296
  • LS-64370
  • MS-28208
  • Cabergoline 1000 microg/mL in Acetonitrile
  • C08187
  • D00987
  • F17353
  • AB01275484-01
  • EN300-19767804
  • Q423308
  • SR-05000001493-1
  • SR-05000001493-2
  • BRD-K86882815-001-01-6
  • Cabergoline, European Pharmacopoeia (EP) Reference Standard
  • Cabergoline, United States Pharmacopeia (USP) Reference Standard
  • ETHYL4-METHYL-2-PYRIDIN-3-YL-1,3-THIAZOLE-5-CARBOXYLATE
  • 6-allyl-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-ergoline-8beta-carboxamide
  • N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-allyl-ergoline-8beta-carboxamide
  • (8-beta)-N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propen-1-yl)ergoline-8-carboxamide
  • (9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
  • 1-[3-(dimethylamino)propyl]-3-ethyl-1-[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene-4-carbonyl]urea
  • ERGOLINE-8.BETA.-CARBOXAMIDE, N-(3-(DIMETHYLAMINO)PROPYL)-N-((ETHYLAMINO)CARBONYL)-6-(2-PROPENYL)-
Click here to view all Cabergoline products